Rift Valley fever (RVF) is a mosquito-borne viral disease that cycles between livestock and humans across much of Africa and the Arabian Peninsula, causing devastating “abortion storms” in sheep and cattle herds and occasionally progressing to hemorrhagic fever, encephalitis, or blindness in people. The virus behind it belongs to the bunyavirus family and carries a segmented RNA genome wrapped in a lipid envelope, a design that gives it both resilience and an unusual capacity to evolve through genetic reassortment. Because outbreaks tend to erupt after abnormal rainfall events linked to climate cycles, RVF sits at a volatile intersection of veterinary medicine, public health, and environmental science, and controlling it demands coordinated action across all three.
How the Virus Is Built
Rift Valley fever virus (RVFV) is an enveloped, single-stranded RNA virus. Its genome is split into three segments designated large (L), medium (M), and small (S), each with negative or ambisense polarity. These segments are packaged inside a nucleocapsid protein shell and then wrapped in a lipid bilayer studded with two surface glycoproteins, Gn and Gc.1PubMed Central. Molecular biology of rift valley Fever virus The L segment encodes the viral RNA-dependent RNA polymerase, the M segment encodes the two glycoproteins along with accessory proteins, and the S segment encodes both the nucleocapsid protein and a nonstructural protein called NSs that plays a central role in virulence.
Structural work on the nucleocapsid has revealed that RVFV organizes its genome quite differently from other negative-sense RNA viruses. When researchers solved the crystal structure of the nucleocapsid protein at near-atomic resolution, they found an extended, non-helical ribonucleoprotein polymer rather than the coiled arrangements seen in related virus families. The protein lacks the positively charged groove typically used for RNA binding in other negative-sense viruses, suggesting RVFV has evolved a distinct strategy for gripping its genome.2PubMed Central. Structure of the Rift Valley fever virus nucleocapsid protein reveals another architecture for RNA encapsidation
The three-segment design carries an evolutionary trade-off. Segmentation allows the virus to reassort its genome when two strains co-infect the same cell, which can generate new genetic combinations rapidly. But it also complicates replication and packaging, since each new virus particle needs at least one copy of every segment to remain infectious.3PLoS Pathogens. Single-Molecule FISH Reveals Non-selective Packaging of Rift Valley Fever Virus Genome Segments
How the Virus Gets Inside a Cell
The two glycoproteins on the viral surface, Gn and Gc, work as a team to get RVFV into a host cell. The virus is taken up by endocytosis, and once inside the acidic environment of a late endosome, a specific histidine residue on the Gc protein becomes protonated. That protonation triggers a dramatic shape change in Gc, converting it into an extremely stable oligomer that drives fusion between the viral envelope and the endosomal membrane, releasing the genome into the cell’s interior. Mutating just one histidine (H857) in Gc completely blocks entry and shuts down the fusion machinery.4PubMed Central. Acid-activated structural reorganization of the Rift Valley fever virus Gc fusion protein
The Gc protein itself has a “class II” fusion protein architecture, a structural fold previously known only from flaviviruses and alphaviruses. This was a surprise when the crystal structure was solved, because bunyaviruses were not thought to share this entry mechanism with those distant viral families.5PubMed Central. Crystal structure of glycoprotein C from Rift Valley fever virus The Gn protein, for its part, sits atop the Gc subunits and helps organize them into hexameric building blocks on the virus surface. Recent cryo-electron microscopy work has mapped the precise contacts between Gn heads within these hexamers, showing how a potent neutralizing antibody can jam the machinery by crosslinking adjacent Gn proteins and locking them in their pre-fusion state.6PubMed Central. Cryo-EM structure of the Rift Valley fever virus envelope protein in complex with a potent neutralization antibody
The NSs Protein and Why the Virus Hits So Hard
The single biggest contributor to RVFV virulence is NSs, a nonstructural protein encoded on the S segment. NSs acts as a saboteur of the host’s innate immune response, specifically by shutting down the production of type I interferons, the signaling molecules that normally alert neighboring cells to a viral invasion.7PubMed Central. Rift Valley Fever Virus-Infection, Pathogenesis and Host Immune Responses The correlation between interferon suppression and virulence is tight: attenuated vaccine strains that carry mutations in the NSs gene trigger robust early interferon production in the host and are far less dangerous, while virulent wild-type strains produce no detectable interferon and replicate extensively.8PubMed Central. Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs
NSs does not rely on a single trick. Research has documented multiple molecular mechanisms through which it interferes with host cell processes: degrading certain host proteins, blocking transcription, and manipulating DNA damage-response pathways. One review described NSs as a “molecular Houdini” for the breadth of its immune-evasion repertoire.9PubMed Central. Immune Evasion by the NSs Protein of Rift Valley Fever Virus: A Viral Houdini Act This versatility makes NSs both an important target for vaccine design and a reason the virus can overwhelm the defenses of otherwise healthy animals and people so quickly during acute infection.
Transmission Through Mosquitoes and Between Outbreaks
RVFV circulates primarily through mosquito bites. Several genera can transmit the virus, but floodwater-breeding Aedes species play a unique role in the virus’s long-term persistence. The leading theory holds that RVFV survives the dry years between outbreaks inside mosquito eggs deposited in the soil around seasonal water basins. When heavy rains flood those basins, the eggs hatch, and the emerging mosquitoes already carry the virus thanks to vertical (mother-to-offspring) transmission.10Journal of General Virology. Rift valley fever virus: Strategies for maintenance, survival and vertical transmission in mosquitoes These initial infections in livestock then draw in secondary vector species, especially Culex mosquitoes, which amplify transmission into a full-blown outbreak.
Humans acquire RVFV in two main ways. The first is through mosquito bites during outbreaks. The second, and often more common route for people who work closely with livestock, is direct contact with infected animal tissues, blood, or birth products. A study of slaughterhouse workers in northern Kenya found that roughly one in five tested positive for antibodies to RVFV, and since most participants did not come from livestock-keeping households, the authors attributed the infections mainly to occupational exposure during butchering.11PLoS Neglected Tropical Diseases. Seroprevalence of Brucella spp. and Rift Valley fever virus among slaughterhouse workers in Isiolo County, northern Kenya No confirmed human-to-human transmission has been documented.
What RVF Does to Animals
In livestock, RVFV is devastating. Sheep are the most susceptible domestic species, followed by cattle and goats. The hallmark of an epizootic is a wave of abortions sweeping through a herd, a phenomenon sometimes called an “abortion storm,” coupled with high mortality in newborn animals.12PLoS Neglected Tropical Diseases. Rift Valley fever virus targets the maternal-foetal interface in ovine and human placentas Adult animals often develop acute liver disease. The sudden loss of breeding stock and young animals can wipe out years of herd-building effort in a single season.
What RVF Does to People
Most human infections produce a self-limiting febrile illness that resolves within a week. A systematic review and meta-analysis cataloging clinical manifestations across the published literature identified nine distinct syndromes associated with RVF, spanning febrile, renal, gastrointestinal, hepatic, hemorrhagic, visual, neurological, cardiopulmonary, and obstetric presentations. Hemorrhagic disease was reported in roughly a quarter of cases that progressed beyond mild illness.13PubMed Central. Clinical manifestations of Rift Valley fever in humans: Systematic review and meta-analysis
Among the more feared complications is ocular disease, which can appear weeks after the initial fever has resolved. Symptoms include blurred vision, uveitis, and retinitis. Animal model studies have shown that the virus directly infects the posterior segment of the eye, including the retina, optic nerve, and choroid, provoking an inflammatory response that can permanently damage vision.14PubMed Central. Rift Valley Fever Virus Infects the Posterior Segment of the Eye and Induces Inflammation in a Rat Model of Ocular Disease Encephalitis and hemorrhagic fever represent the other two severe endpoints, and all three can be fatal.15PubMed Central. Potential for autoimmune pathogenesis of Rift Valley Fever virus retinitis
Climate Patterns That Trigger Outbreaks
RVF outbreaks do not appear at random. In East Africa, more than three-quarters of historically documented outbreaks have coincided with warm-phase El Niño events, which bring above-normal rainfall to the region and flood the seasonal basins where vector mosquitoes breed.16PubMed. Climate-disease connections: Rift Valley Fever in Kenya The relationship is strong enough that satellite-based monitoring of sea surface temperatures, rainfall, and vegetation greenness was used to successfully predict the 2006–2007 Horn of Africa outbreak months before human and animal cases peaked.17PubMed Central. Prediction of a Rift Valley fever outbreak
The picture is not limited to El Niño alone. When the Pacific climate cycle shifts from El Niño to La Niña, the center of anomalous rainfall moves southward, and so does the risk. East African outbreaks in 2006–2007 occurred during the El Niño phase, while outbreaks in Southern Africa in 2008–2009 followed the subsequent La Niña transition.18PLoS Neglected Tropical Diseases. Climate Teleconnections and Recent Patterns of Human and Animal Disease Outbreaks This shifting geography makes forecasting more nuanced than simply watching for El Niño. The underlying principle, though, is consistent: prolonged above-normal rainfall fills breeding habitats, hatches infected eggs, and sets the stage for amplification through secondary vectors and susceptible livestock.
Satellite Surveillance and Early Warning
The predictability of RVF’s climate triggers has opened the door to early warning systems that combine satellite data with mosquito population models. One approach uses synthetic aperture radar to track free water levels in small ponds across the landscape, paired with near-real-time rainfall data, to map where and when mosquito breeding is likely to peak. This kind of monitoring can work regardless of cloud cover and provides spatial resolution fine enough to identify individual pond basins, letting authorities assess risk at the scale of a livestock park or village.19PubMed. TerraSAR-X high-resolution radar remote sensing: an operational warning system for Rift Valley fever risk
Complementary work has used satellite-derived temperature, humidity, and rainfall estimates as inputs for process-based models of mosquito population dynamics. In northern Senegal, this approach produced weekly regional maps of projected vector abundance for three RVF-capable species, giving public health officials a tool to prioritize surveillance and vector control efforts before cases appear.20Remote Sensing. Spatial Modeling of Mosquito Vectors for Rift Valley Fever Virus in Northern Senegal: Integrating Satellite-Derived Meteorological Estimates in Population Dynamics Models These systems are not perfect predictors, but they give weeks or months of lead time compared to waiting for the first clinical reports.
Vaccines for Livestock
Vaccination of livestock is widely considered the most effective single intervention for preventing RVF outbreaks, because breaking the cycle in animals starves the virus of the amplification it needs to spill over into people. Several veterinary vaccines exist. The Clone 13 live-attenuated vaccine, which carries a deletion in the NSs gene and therefore cannot suppress host interferon, has been tested across sheep, goats, and cattle in Tanzania with no adverse reactions at injection sites and no vaccine-associated abortions or deaths.21PubMed Central. Safety, Immunogenicity and Antibody Persistence of Rift Valley Fever Virus Clone 13 Vaccine in Sheep, Goats and Cattle in Tanzania
Modeling work by the European Food Safety Authority underscores that timing matters more than vaccine perfection. Their analysis found that when vaccination begins at least 30 days before virus introduction and proceeds at a reasonable pace, the epidemic can be kept below a few percent of the herd, regardless of whether the vaccine itself has 60% or 90% effectiveness. In all scenarios modeled, vaccinating 200 or more animals per day halted epidemics within a year.22PubMed Central. Scientific Opinion on Rift Valley Fever – assessment of effectiveness of surveillance and control measures in the EU The practical takeaway is that getting a vaccination campaign started early and moving quickly matters far more than the specific vaccine formulation used.
Human Vaccine Development
No licensed human vaccine for RVF exists yet, but two candidates are furthest along. The MP-12 live-attenuated vaccine, tested in a Phase 2 clinical trial, was well tolerated, and all 19 subjects developed neutralizing antibodies within a month of a single dose. Five years later, nearly nine out of ten still had protective antibody levels, suggesting strong durability.23PubMed Central. Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates
A newer candidate, hRVFV-4s, uses a different attenuation strategy and recently completed a first-in-human Phase 1 dose-escalation trial. No serious adverse events were reported, and at the highest dose tested, every participant developed neutralizing antibodies by day 28. Notably, no vaccine virus RNA was detected in blood, saliva, urine, or semen samples from any participant, addressing a common safety concern with live vaccines. Neutralizing antibody levels did decline over time, but antibodies against the nucleocapsid protein remained stable for at least six months.24PubMed. Safety and immunogenicity of the live-attenuated hRVFV-4s vaccine against Rift Valley fever in healthy adults Both candidates still need larger efficacy trials before licensure, and the economic challenge of developing a vaccine for a disease that occurs in unpredictable outbreaks in low-income regions remains a significant barrier.
The Risk of Geographic Spread
RVF has historically been confined to sub-Saharan Africa, with periodic extensions into Egypt and a single major outbreak on the Arabian Peninsula in 2000. But the ingredients for wider spread already exist. Unregulated live animal trade routes move potentially infected animals through endemic zones, and mosquito species capable of transmitting RVFV are already established well beyond Africa’s borders. A meta-analysis of vector competence data for five Mediterranean mosquito species found that Aedes caspius was likely the most competent potential vector in the region, and both Culex pipiens and Aedes albopictus (the Asian tiger mosquito) are present across southern Europe.25PubMed Central. Vector Competence of Mediterranean Mosquitoes for Rift Valley Fever Virus: A Meta-Analysis
Laboratory experiments with European Culex pipiens and Aedes albopictus populations from Spain confirmed that both species could become infected, allow the virus to disseminate to their salivary glands, and transmit infectious particles, demonstrating genuine transmission capacity rather than just susceptibility to infection.26PubMed. Rift Valley fever virus and European mosquitoes: vector competence of Culex pipiens and Stegomyia albopicta (= Aedes albopictus) Whether an introduction would spark a sustained outbreak depends on many additional factors, including livestock density, veterinary surveillance capacity, and the timing of any introduction relative to mosquito season. But the biological prerequisites for autochthonous transmission are already in place in parts of southern Europe and elsewhere.
Reassortment and Viral Evolution
The segmented genome that complicates RVFV packaging also gives the virus a potent evolutionary tool. When two different RVFV strains infect the same cell, their genome segments can mix and match during replication, producing offspring with novel combinations of L, M, and S segments. Phylogenetic analyses have confirmed multiple reassortment events among field isolates across Africa, including reassortants found in both human and animal hosts and at least one case involving a wild virus and a live vaccine strain in South Africa.27PubMed Central. Molecular epidemiology of Rift Valley fever virus
Detailed evolutionary analysis has shown that the three genome segments do not evolve at the same pace. The M segment accumulates mutations roughly one and a half times faster than the L segment, and the segments show periods during which their effective population sizes move in opposite directions, a statistical fingerprint of reassortment shuffling lineages between segments independently.28Scientific Reports. Reassortment and distinct evolutionary dynamics of Rift Valley Fever virus genomic segments Currently, 15 recognized lineages of RVFV circulate in sub-Saharan Africa, shaped by a combination of gradual mutation, geographic migration, and reassortment driven by environmental changes and livestock movement.29PubMed Central. Genomic surveillance of Rift Valley fever virus: from sequencing to lineage assignment This genetic fluidity is relevant to vaccine design, since a vaccine built around one lineage could theoretically face a reassortant that partially evades immunity, and to outbreak investigation, since genomic surveillance can trace the origins and movement of a new epidemic strain.
Economic Damage Beyond Livestock Deaths
The economic footprint of an RVF outbreak extends far beyond the direct loss of animals. A rapid review of socioeconomic impacts found that the 2006 Kenyan outbreak caused an estimated $9.3 million in livestock fatalities alone, but the downstream effects were far wider. Livestock trade bans, imposed to prevent further spread, shut down entire market chains, cutting off income not just for herders but for abattoir workers, transporters, butchers, and traders in animal products like milk, hides, and manure. Reduced market prices for the animals that could still be sold further eroded household income.30PLOS Neglected Tropical Diseases. The socioeconomic impacts of Rift Valley fever: A rapid review
For pastoralist and agropastoralist communities in East Africa, where livestock represent savings, insurance, and daily nutrition all at once, these disruptions can be catastrophic. Research in Tanzania documented impacts that included human and animal deaths, monetary losses at both individual and national levels during disease-control efforts, inability to meet daily needs, and malnutrition from the loss of animal protein sources.31PubMed Central. Socio-economic impact of Rift Valley fever to pastoralists and agro pastoralists in Arusha, Manyara and Morogoro regions in Tanzania Tourism, petroleum distribution, and public health systems were also affected. The cascade makes a strong economic case for investing in surveillance and preemptive livestock vaccination even when outbreaks are years apart.
One Health and Point-of-Care Diagnostics
Because RVFV moves between mosquitoes, livestock, and people across shared landscapes, controlling it through any single lens is insufficient. The “One Health” framework, which integrates veterinary, human-health, and environmental perspectives, has been widely endorsed as the appropriate model for RVF management. A key principle is engaging local communities not as passive victims but as active participants in surveillance and reporting, since herders are often the first to notice unusual livestock deaths or abortion waves.32PubMed Central. The One Health Approach is Necessary for the Control of Rift Valley Fever Infections in Egypt: A Comprehensive Review
Rapid diagnostics are a practical bottleneck. Most RVF-endemic areas lack the biosafety infrastructure for conventional laboratory confirmation, and samples often degrade during transport to reference labs. New point-of-care tools are being developed to address this. A recently described vertical flow immunoassay, for example, is designed to be deployed directly in resource-limited field settings, giving frontline workers the ability to confirm suspected cases without waiting for centralized lab results.33PubMed Central. Development of a high-sensitivity vertical flow immunoassay for the detection of Rift Valley fever virus Faster confirmation at the point of exposure feeds directly into the early warning systems described above, tightening the loop between detection and response and shortening the window during which an outbreak can grow unnoticed.